Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02686229

Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas

The LoG-Glio-Registry is based on a network of german hospitals gathering radiological, clinical, epidemiological and molecular data on all patients diagnosed with a low grade glioma.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Glioma Brain Diseases Brain Neoplasms Central Nervous System Diseases Central Nervous System Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neoplasms, Neuroepithelial Nervous System Diseases Nervous System Neoplasms Neuroectodermal Tumors

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Ulm

Ulm, Germany

Location status: Recruiting

Location contact

Jan Coburger, MD

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with radiological suspected diagnosis of a low grade glioma
  • Age ≥ 18 years. There is no upper age limit.

Exclusion criteria

  • Severe neurological or psychiatric disorder interfering with ability to give an informed consent
  • No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation
  • No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.

Treatment and study plan

No interventions

Other

Primary outcomes

  1. Progression-free survival (PFS)

    Time frame: 5yrs

  2. Overall survival (OS)

    Time frame: 15yrs

Secondary outcomes

  1. Extent of tumor resection

    Time frame: 3yrs

    calculated based on volumetric assessement of tumor in cm³ and residual tumor in pre and postoperative MRI

  2. Quality of life (QoL) assessed by the EORTC QLQ C-30/BN-20. (European Organisation for Research and Treatment of Cancer Quality of Life Questionaire C-30

    Time frame: 5yrs

Study contacts

Contact information is provided by the study sponsor or research team.

Jan Coburge, MD

CONTACT

[email protected]

082219628858

Sponsors and collaborators

Lead sponsor

University of Ulm

Other

Collaborators

  • Charite University, Berlin, Germany

Registry information

Official study title

Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas: The LOG-Glio-Project

Acronym: LoG-Glio

Important dates

Study start
2015
Primary completion
2026
Study completion
2036
First posted
Feb 19, 2016
Registry last updated
May 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.